BNET Industries

Market Cap:$70.8M
Last Fiscal Year Sales:$5.3M
  • Public
  • US
Dow Jones Description

We incorporated under the laws of the State of California in April 1999 as Micromed Laboratories, Inc. In August 2001, we changed our name to Oculus Innovative Sciences, Inc. In December 2006, we reincorporated under the laws of the State of Delaware. Our principal executive offices are located at 1129 N. McDowell Blvd., Petaluma, California, 94954, and our telephone number is (707) 782-0792. We have two principal subsidiaries: Oculus Technologies of Mexico, S.A. de C.V., organized in Mexico, and Oculus Innovative Sciences Netherlands, B.V., organized in the Netherlands. On January 20, 2009, we dissolved our subsidiary, Oculus Innovative Sciences Japan, KK., organized under Japanese law. Our fiscal year end is March 31. Our website is www.oculusis.com . We do not intend for information on our website to be incorporated into this 10-K. Our Business We develop, manufacture and market, a family of products intended to significantly reduce the need for antibiotics as it prevents and treats infections in chronic and acute wounds while simultaneously enhancing wound healing through modes of action unrelated to the treatment of infection. Infection is a serious potential complication in both chronic and acute wounds, and controlling infection is a critical step in wound healing. ...

President, Chief Executive Officer and Chairman of The Board (Principal Executive Officer)Hojabr Alimi
Number of Employees 79
Contact Information

1129 N McDowell Blvd

Petaluma, California 94954

oculusis.com

(707) 283-0550

NAICS Code Surgical and Medical Instrument Manufacturing: 339112

Recent Events

  • FDA Chimes in as Oculus Reportedly Preps Stock Sale

    6/22/09 - Financial Announcement - View Story

  • Oculus Innovative Sciences, Inc. OCLS Reports FY 2009 Financial Results and Discusses Worldwide Revenue Growth...

    6/12/09 - Financial Announcement - View Story

  • Oculus Innovative Sciences Reports Third Quarter Product Revenue Up 19% with a $2.6 Million Reduction...

    2/12/09 - Financial Announcement - View Story

News & Analysis

oculus innovative sciences inc. - All News and Analysis

Additional Resources

Decision Makers

Name (plus bio) Position
Robert E. Miller CFO
Robert S. Miller Chief Financial Officer
Bruce Thornton Executive Vice President
Jim Schutz Vice President of Corporate Development, General Counsel, Corporate Secretary and Director
Michelle Carpenter Vice President of Regulatory and Quality
ANDRES A GUTIERREZ Director of Medical Affairs
Dan McFadden Director of Public and Investor Relations
Robert Northey Director of Research and Development
Sergio Caleti Del Mazo Director of Sales and Marketing Mexico
Jesus Grajeda National Sales Manager Mexico
BRUCE C WILSON Consultant
Richard Conley Director

Board of Directors

Name (plus bio) Position
Hojabr Alimi President, Chief Executive Officer and Chairman of The Board (Principal Executive Officer)
Akito Ohmura Board of Directors
David Allie Board of Directors
DON C WUKASCH Board of Directors
Gerald L Woolam Board of Directors
Greg French Board of Directors
Gregg H. Alton Board of Directors
Jay E. Birnbaum Board of Directors
Luca Dalla Paola Board of Directors
Ned Brown Board of Directors
PAUL L SCHNUR Board of Directors
Phillip J Kearney Board of Directors
RICHARD M MARKS Board of Directors
Robert Burlingame Board of Directors

Hojabr Alimi , one of our founders, has served as our Chief Executive Officer, President and director since 1999 and was appointed as Chairman of the board of directors in June 2006. Prior to co-founding our company with his spouse in 1999, Mr. Alimi was a Corporate Microbiologist for Arterial Vascular Engineering. Mr. Alimi received a B.A. in biology from Sonoma State University.

Organization Position Status
Oculus Innovative Sciences, Inc. President, Chief Executive Officer and Chairman of The Board (Principal Executive Officer) Current
Oculus Innovative Sciences, Inc. Board of Directors Former
Sonoma State University B.A. In Biology Former
Organization Position Status
Oculus Innovative Sciences, Inc. CFO Current
Organization Position Status
Slam Dunk Networks, Inc. CEO Current
Onstor Inc Chairman and CEO Current
Scanis, Inc. Acting Chief Financial Officer Current
Oculus Innovative Sciences, Inc. Chief Financial Officer Current
Slam Dunk Networks, Inc. Founder Current
The New Environmentalist Current
Advanced Internet Security, Inc. Current
Greenborder Technologies, Inc. Current
ONStor, Inc. Current
Federal-Mogul Corporation chairman Current
UAL Corporation Executive Chairman, Delphi Corporation Current
Urban Institute Board of Directors Current
Symantec Corporation Board of Directors Current
Waste Management, Inc. Director Current
Scanis, Inc. Director Current
Nexlan, LLC Board of Directors Current
Urban Institute Trustee Current
Bethlehem Steel Chief Executive Officer Former
Waste Management, Inc. Chief Executive Officer Former
Reliance Group Holdings, Inc. President Former
Reliance - ADA Group President Former
The Bugle Boy, LLC Chief Financial Officer Former
GAF Corporation Chief Financial Officer Former
James D. Wolfensohn, Inc. Senior Partner Former
Oculus Innovative Sciences, Inc. Finance Executive Former
Federal-Mogul Corporation parts supplier Former
Merrill Lynch & Co., Inc. Former
Bethlehem Steel Chairman Former
Waste Management, Inc. Miller was Chairman Former
Federal-Mogul Corporation Director Former
Delphi Corporation Board of Directors Former
Mead Corporation Treasurer Former
New Mexico State University Master of Science Degree In Mechanical Engineering Former
Columbia University M.B.A. In Finance Former
Stanford Graduate School of Business Master's Former
Stanford University Masters of Business Administration Former
Bucknell University B.S. In Mechanical Engineering Former
Columbia University Bachelor of Science Degree In Mechanical Engineering Former
Augustana College Bachelor of Arts Degree In Physics Former
Stanford University B.A. In Economics Former
Stanford University Degree In Economics Former
Harvard Law School Degree Former
Symantec Corporation member Former

Bruce Thornton has served as our vice president of international operations and sales since June 2005. Mr. Thornton served as our general manager for U.S. operations from March 2004 to July 2005. He served as vice president of operations for Jomed (formerly EndoSonic Corp.) from January 1999 to September 2003, and as vice president of manufacturing for Volcano Therapeutics, an international medical device company, following its acquisition of Jomed, until March 2004. Mr. Thornton received a B.S. in aeronautical science from Embry-Riddle Aeronautical University and an M.B.A. from National University.

Organization Position Status
Oculus Innovative Sciences, Inc. Executive Vice President Current
Oculus Innovative Sciences, Inc. Vice President International Operations and Sales Current
Embry-Riddle Aeronautical University B.S. In Aeronautical Science Former

James Schutz has served as our vice president of corporate development and general counsel since August 2003, as a director since May 2004 and corporate secretary since June 2006. From August 2001 to August 2003, Mr. Schutz served as general counsel at Jomed (formerly EndoSonic Corp.), an international medical device company. From 1999 to July 2001, Mr. Schutz served as in-house counsel at Urban Media Communications Corporation, an Internet/telecom company based in Palo Alto, California. Mr. Schutz received a B.A. in economics from the University of California, San Diego and a J.D. from the University of San Francisco School of Law.

Organization Position Status
Oculus Innovative Sciences, Inc. Vice President of Corporate Development, General Counsel, Corporate Secretary and Director Current
Oculus Innovative Sciences, Inc. Board of Directors Current
University of San Francisco School of Law J.D. Former
University of San Francisco School of Law law degree Former
University of California, San Diego B.A. In Economics Former
Organization Position Status
Dey Laboratories, Inc. Dey's Chief Compliance Officer Current
Oculus Innovative Sciences, Inc. Vice President of Regulatory and Quality Current
Santen Inc. Current
Dey L.P. Chief Compliance Officer Former
Dey L.P. Vice President of Regulatory Former
InSite Vision Incorporated Former
Golden Gate University Law degree Former
University of California, Santa Barbara Bachelors degree Former
Organization Position Status
Oculus Innovative Sciences, Inc. Director of Medical Affairs Current
National University M.D. Former
Hammersmith Hospital Fellow Former
Organization Position Status
Oculus Innovative Sciences, Inc. Director of Public and Investor Relations Current

Robert Northey, Ph.D. has served as our director of research and development since July 2005. Dr. Northey served as a consultant to us from May 2001 to June 2005. From August 1998 until June 2005, he was an assistant professor in the paper science and engineering department at the University of Washington. Dr. Northey received a B.S. in wood and fiber science and a Ph.D. in wood chemistry, each from the University of Washington.

Organization Position Status
Oculus Innovative Sciences, Inc. Director of Research and Development Current
University of Washington Assistant Professor Former
University of Washington Ph.D. In Wood Chemistry Former
University of Washington B.S. In Wood Former
Organization Position Status
Oculus Innovative Sciences, Inc. Director of Sales and Marketing Mexico Current
Organization Position Status
Oculus Innovative Sciences, Inc. National Sales Manager Mexico Current
Organization Position Status
Heart Hospital Founder Current
Heartmath LLC Medical Director Current
Oculus Innovative Sciences, Inc. Consultant Current
Freeze-Framer Trainer Current
Medical College of Wisconsin Associate Professor of Medicine Current
Wilson Heart Care Board Certified Cardiologist Current
Heartmath LLC Board of Directors Current
Oculus Innovative Sciences, Inc. Board of Directors Current
Quantum Intech, Inc Board of Directors Current
American College of Cardiology Fellow Current
Heartmath LLC Trainer Former
Columbia Hospital LP chairman Former
University of Wisconsin Medical School Former
Organization Position Status
Oculus Innovative Sciences, Inc. Board of Directors Current
Organization Position Status
Oculus Innovative Sciences, Inc. Board of Directors Current
American College of Cardiology Fellow Current
American College of Surgeons Fellow Current
American College of Chest Physicians Fellow Current
Organization Position Status
The University of Texas Diplomat Current
Oculus Innovative Sciences, Inc. Board of Directors Current
Amd Telemedicine, Inc. Former
Organization Position Status
Lubbock Surgical Surgeon Current
Texas Tech University Professor Current
Oculus Innovative Sciences, Inc. Board of Directors Current
American Cancer Society, Inc. President Former
Baylor College of Medicine M.D. Degree Former
Texas Tech University B.A. Former

Gregory French has served as a director since 2000. Mr. French is owner and chairman of the board of G&C Enterprises LLC, a real estate and investment company, which he founded in 1999. He held various engineering and senior management positions at several medical device companies, including Advanced Cardiovascular Systems, Peripheral Systems Group and Arterial Vascular Engineering. Mr. French received a B.S.I.E. from the California State Polytechnic University, San Luis Obispo.

Organization Position Status
Oculus Innovative Sciences, Inc. Board of Directors Current
Sonoma Academy Board of Directors Current
Northern Telecom Product Manager Former
Octel Communications Senior Marketing Manager Former
California State Polytechnic University B.S.I.E. Former
California Polytechnic State University Former

Gregg Alton has served as a director since January 2008. Mr. Alton is currently a senior vice president, general counsel and secretary at Gilead Sciences, Inc. His expertise lies in the areas legal affairs, public affairs, government affairs, and international access operations of publicly traded biopharmaceutical company. In addition, Mr. Alton is a member and chairman of Gilead Healthcare PAC, and a member of the board of Gilead Foundation. Since joining Gilead Sciences Inc. as associate general counsel in 1999, Mr. Alton has managed the company's departments of U.S. and European legal affairs; intellectual property; public affairs; international access operations; government affairs; and global government affairs. Previously, Mr. Alton was a corporate associate at the mergers and acquisitions group Cooley Godward LLP, where he counseled technology and biotechnology clients in transaction structures and related documentation. Prior to that, Mr. Alton served a similar role as a corporate associate at Mintz, Levin, Cohn, Ferris, Glovsky & Popeco. He received a BA in legal studies from the University of California at Berkeley, and a JD from Stanford Law School.

Organization Position Status
Gilead Sciences, Inc. Senior Vice President Current
Phcentral, Inc Senior Vice President and General Counsel Current
BayBio Senior Vice President Current
Gilead Sciences, Inc. General Counsel Current
G.I.L.E.A.D Inc. Current
BayBio Member, Board of Directors Current
Oculus Innovative Sciences, Inc. Board of Directors Current
Biotechnology Industry Organization Treasurer Current
Aids Healthcare Foundation Member, Board of Directors Current
Gilead Sciences, Inc. Secretary Current
Cooley Godward Llp Attorney Former
Stanford Law School J.D Former
Stanford University Jd Former
University of California, Berkeley B.A. In Legal Studies Former

Jay Birnbaum has served as a director since April 2007. Dr. Birnbaum is a pharmacologist and previous to his current role as a consultant to pharmaceutical companies, he served as vice president of global project management at Novartis/Sandoz Pharmaceuticals Corporation, where he had responsibility for strategic planning and development of the company's dermatology portfolio. Dr. Birnbaum is a co-founder of Kythera Biopharmaceuticals, a company developing products in aesthetic and restorative dermatology, as well as a member of NanoBio Corporation's scientific advisory board. He received both an M.S. and Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.

Organization Position Status
Kythera Biopharmaceuticals, Inc. Co-Founder Current
Nanobio Board of Directors Current
International Society of Dermatology Board of Directors Current
Oculus Innovative Sciences, Inc. Board of Directors Current
Kythera Biopharmaceuticals, Inc. Board of Directors Current
Transport Pharmaceuticals, Inc Board of Directors Current
American Academy of Dermatology Board of Directors Current
Nanobio Member Current
Kythera Biopharmaceuticals, Inc. Chief Medical Officer Former
University of Wisconsin PhD In Pharmacology Former
University of Wisconsin M.S. Former
Trinity College M.S. Former
Trinity College BS In Biology Former
Organization Position Status
Oculus Innovative Sciences, Inc. Board of Directors Current
Organization Position Status
Tpg Growth Managing Director Current
Angiotech Pharmaceuticals, Inc. Managing Director, Tpg Growth Current
Oculus Innovative Sciences, Inc. Board of Directors Current
Replidyne, Inc. Board of Directors Current
Angiotech Pharmaceuticals, Inc. Board of Directors Current
Healthcare Investment Partners Managing Director Former
The Health Care Group Managing Director Former
University of California, Los Angeles M.B.A. Former
University of Oxford Masters of Philosophy degree Former
Anderson School of Management MBA Former
Middlebury College A.B. degree Former

Dr. Schnur is past chairman of the division of plastic surgery, Mayo Clinic Arizona. He is past president of The American Society of Plastic Surgeons and Associate Professor of Plastic Surgery at Mayo Medical School and University of Arizona College of Medicine.

Organization Position Status
Mayo Medical School Associate Professor of Plastic Surgery Current
Oculus Innovative Sciences, Inc. Board of Directors Current
Mayo Graduate School of Medicine associate professor Former
Mayo Clinic chairman Former
Mayo Clinic Director Former
Organization Position Status
Oculus Innovative Sciences, Inc. Board of Directors Current

Richard Conley has served as a director since 1999, and served as our secretary from July 2002 to June 2006. Since April 2001, Mr. Conley has served as executive vice president and chief operating officer at Don Sebastiani & Sons International Wine Negociants, a branded wine marketing company. From 1994 to March 2001, he served as senior vice president and chief operating officer at Sebastiani Vineyards, a California wine producer, where he was originally hired as chief financial officer in 1994. Mr. Conley received a B.S. in finance and accounting from Western Carolina University and an M.B.A. from St. Mary's University.

Organization Position Status
Oculus Innovative Sciences, Inc. Director Current
Sebastiani Former
PepsiCo, Inc. Former
St. Mary's University M.B.A. Former
St. Mary's University B.S. In Finance Former
Organization Position Status
Oculus Innovative Sciences, Inc. Board of Directors Current
Techniques Board of Directors Current

Robert Burlingame has served as a director since November 2006. Mr. Burlingame is the chief executive officer and chairman of the board of Burlingame Industries, Inc., a manufacturer of automated equipment specializing in the concrete rooftile industry, which he founded in 1969. He has held various senior management positions at several rooftile companies, including California Tile and Lifetile Corporation. Mr. Burlingame received a B.S. in business from Michigan State University and was a pilot in the U.S. Navy.

Organization Position Status
Burlingame Industries, Incorporated Chief Executive Officer Current
Oculus Innovative Sciences, Inc. Board of Directors Current
Burlingame Industries, Incorporated Chairman & President Former
Michigan State University B.S. In Business Former

Executive News

  • FDA Chimes in as Oculus Reportedly Preps Stock Sale

    TheStreet.com - 6/22/09 - View Story

  • UAL Corporation's Annual Meeting Highlights United's Resiliency and Shareholders...

    Reuters - 6/11/09 - View Story

  • UAL Corporation's Annual Meeting Highlights United's Resiliency and Shareholders Re-Elect Board...

    Forbes.com - 6/11/09 - View Story

  • UAL Corporation's Annual Meeting Highlights United's Resiliency and Shareholders Re-Elect Board of Directors

    PR Newswire - 6/11/09 - View Story

advertisement
     OCLS $3.27 -0.03 (-0.91% )
Average Volume 1,081,890
Shares Outstanding 20.14M
Market Cap 65.8M
Year High 5.75
Year Low 0.2
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
advertisement